麦迪逊运动 MSGS 深 沪
等待开盘 08-13 09:30:00 美东时间
198.03
-4.450
-2.20%
华盛通- 最 高204.51
- 今 开202.48
- 成交量 25.71万股
- 最 低 193.20
- 昨 收 202.48
- 总市值 47.56亿
- 52周最高 237.9924
- 市盈率 静 81.19
- 换手率 1.07%
- 52周最低 173.26
- 委 比 48.65%
- 总股本 2401.76万
- 历史最高 254.94
- 量 比 1.76
- 振 幅 5.59%
- 历史最低 64.04
- 每 手 1
- 风险率 13.03%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Madison Square Garden Q4 EPS $(0.07) Beats $(0.11) Estimate, Sales $203.957M Beat $151.003M Estimate
Madison Square Garden (NYSE:MSGS) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.11) by 38.05 percent. This is a 106.6 percent decrease over earnings of $1.06 per share
08-12 19:31
Earnings Scheduled For August 12, 2025
Companies Reporting Before The Bell • Smithfield Foods (NASDAQ:SFD) is expected...
08-12 16:32
A Preview Of Madison Square Garden's Earnings
Madison Square Garden (NYSE:MSGS) will release its quarterly earnings report on...
08-11 22:03
MSG Sports scores as Lakers' record sale price sets new benchmark
Shares of Madison Square Garden Sports (NYSE:MSGS) jumped after the record-breaking $10 billion sale of the Los Angeles Lakers boosted perceived valuations for marquee franchises owned by Madison Squa...
06-21 02:17
The Smart Money Is Buying These 10 Stocks
I got into the investment business on a steady diet of Graham and Whitman. But ...
05-21 04:50
MSG Sports Amends Media Rights Agreements
Madison Square Garden Sports ( ($MSGS) ) has issued an update. On April 24, 202...
04-25 18:58
No Slam Dunk for Knicks Owner MSGS After Record-Breaking $6.1B Boston Celtics Sale
It may have been a record-breaking slam dunk deal, but the reported $6.1 billio...
03-22 00:30
What's Going On With Madison Square Garden Stock Thursday?
Madison Square Garden Sports Corp. (NYSE:MSGS) stock is trading higher on Thursday after the Boston Celtics were sold for $6.1 billion, raising the bar for NBA team valuations.
03-21 02:27
美股大行评级 | Stifel：维持Agilon Health"持有"评级，目标价从2美元升至3美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1101791398596456448.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Piper Sandler：维持Prothena Corp(PRTA)"超配"评级，目标价从94美元升至110美元</p> <p>• HC Wainwright & Co.：维持Karyopharm Therape
02-27 11:06
